Significant Ownership of Raymond Prudo-Chlebosz

Signature - Title: /s/ Ray Prudo, M.D. - Ray Prudo, Reporting Person
Location: London
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Raymond Prudo-Chlebosz.

Notify me when Raymond Prudo-Chlebosz files a new Schedule 13D/G report.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
AKTX	Akari Therapeutics Plc	Ordinary Shares, $0.000000005 par value	8.9%	$2,013,918,352	+$831,534,160	8,391,326,467	+70%	Ray Prudo, M.D.	02 Mar 2026

Schedules 13D/G Reported by Raymond Prudo-Chlebosz:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.